Immediate Impact
62 standout
Citing Papers
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment
2024 Standout
Frailty in Older Adults
2024 Standout
Works of Jeffrey Skinner being referenced
Long‐term follow‐up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic‐phase chronic myeloid leukemia
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jeffrey Skinner | 182 | 157 | 93 | 16 | 213 | |
| F. Giles | 176 | 151 | 101 | 18 | 240 | |
| Peter Schuld | 134 | 109 | 53 | 15 | 192 | |
| G. J. Ossenkoppele | 254 | 201 | 131 | 15 | 270 | |
| Alex Allepuz | 94 | 70 | 35 | 14 | 127 | |
| Soo-Young Choi | 142 | 114 | 56 | 18 | 215 | |
| Shanti Amé | 164 | 114 | 53 | 17 | 196 | |
| Ernst Schlögl | 186 | 153 | 57 | 13 | 287 | |
| Wanke Zhao | 91 | 86 | 36 | 14 | 174 | |
| Odoardo Maria Olimpieri | 104 | 108 | 50 | 11 | 218 | |
| Afaf E.G. Osman | 106 | 57 | 22 | 19 | 183 |
All Works
Loading papers...